Literature DB >> 23190229

Multidrug-resistant tuberculosis.

Lia D'Ambrosio, Rosella Centis, Giovanni B Migliori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23190229      PMCID： PMC4671196          DOI： 10.1056/NEJMc1210001

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Confronting multidrug-resistant tuberculosis.

Authors:  Richard E Chaisson; Eric L Nuermberger
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

Review 2.  Scaling up interventions to achieve global tuberculosis control: progress and new developments.

Authors:  Mario Raviglione; Ben Marais; Katherine Floyd; Knut Lönnroth; Haileyesus Getahun; Giovanni B Migliori; Anthony D Harries; Paul Nunn; Christian Lienhardt; Steve Graham; Jeremiah Chakaya; Karin Weyer; Stewart Cole; Stefan H E Kaufmann; Alimuddin Zumla
Journal:  Lancet       Date:  2012-05-19       Impact factor: 79.321

3.  Delamanid for multidrug-resistant pulmonary tuberculosis.

Authors:  Maria Tarcela Gler; Vija Skripconoka; Epifanio Sanchez-Garavito; Heping Xiao; Jose L Cabrera-Rivero; Dante E Vargas-Vasquez; Mengqiu Gao; Mohamed Awad; Seung-Kyu Park; Tae Sun Shim; Gee Young Suh; Manfred Danilovits; Hideo Ogata; Anu Kurve; Joon Chang; Katsuhiro Suzuki; Thelma Tupasi; Won-Jung Koh; Barbara Seaworth; Lawrence J Geiter; Charles D Wells
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

Review 4.  Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.

Authors:  Giovanni Battista Migliori; Miranda W Langendam; Lia D'Ambrosio; Rosella Centis; Francesco Blasi; Emma Huitric; Davide Manissero; Marieke J van der Werf
Journal:  Eur Respir J       Date:  2012-05-31       Impact factor: 16.671

Review 5.  Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis.

Authors:  Marieke J van der Werf; Miranda W Langendam; Emma Huitric; Davide Manissero
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671
  5 in total
  2 in total

1.  Cost-effectiveness analysis of interventions for tuberculosis control: DALYs versus QALYs.

Authors:  R Diel; N Lampenius
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

2.  Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.

Authors:  Vija Skripconoka; Manfred Danilovits; Lea Pehme; Tarmo Tomson; Girts Skenders; Tiina Kummik; Andra Cirule; Vaira Leimane; Anu Kurve; Klavdia Levina; Lawrence J Geiter; Davide Manissero; Charles D Wells
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.